Correlation Between Regeneron Pharmaceuticals and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regeneron Pharmaceuticals and Ascletis Pharma, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Ascletis Pharma.
Diversification Opportunities for Regeneron Pharmaceuticals and Ascletis Pharma
-0.67 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Regeneron and Ascletis is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Ascletis Pharma go up and down completely randomly.
Pair Corralation between Regeneron Pharmaceuticals and Ascletis Pharma
Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Ascletis Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Regeneron Pharmaceuticals is 1.2 times less risky than Ascletis Pharma. The stock trades about -0.54 of its potential returns per unit of risk. The Ascletis Pharma is currently generating about -0.21 of returns per unit of risk over similar time horizon. If you would invest 17.00 in Ascletis Pharma on August 1, 2024 and sell it today you would lose (1.00) from holding Ascletis Pharma or give up 5.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Regeneron Pharmaceuticals vs. Ascletis Pharma
Performance |
Timeline |
Regeneron Pharmaceuticals |
Ascletis Pharma |
Regeneron Pharmaceuticals and Ascletis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Regeneron Pharmaceuticals and Ascletis Pharma
The main advantage of trading using opposite Regeneron Pharmaceuticals and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.Regeneron Pharmaceuticals vs. Crispr Therapeutics AG | Regeneron Pharmaceuticals vs. Novo Nordisk AS | Regeneron Pharmaceuticals vs. Sarepta Therapeutics | Regeneron Pharmaceuticals vs. Intellia Therapeutics |
Ascletis Pharma vs. PsyBio Therapeutics Corp | Ascletis Pharma vs. Cellectis SA | Ascletis Pharma vs. TC BioPharm plc | Ascletis Pharma vs. Opthea |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |